Atossa Therapeutics (ATOS) Share-based Compensation (2011 - 2026)
Atossa Therapeutics (ATOS) recorded Share-based Compensation of $815,000 in Q2 2026, up 2.4% from $796,000 a year earlier and up 12.9% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Share-based Compensation (2011 - 2026) Analysis & Trends
On a TTM basis, Atossa Therapeutics' Share-based Compensation came in at $2.82 million as of Jun 30, 2026, down 2.0% year-over-year; for FY2025, it came in at $2.65 million, up 15.4% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $2.29 million in FY2024 (-50.4%), $4.62 million in FY2023 (-31.9%), $6.79 million in FY2022 (+28.9%) and $5.27 million in FY2021 (+74.5%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation since Q3 2023.
- On a year-over-year basis, Share-based Compensation rose in six of the last eight quarters, with growth averaging 23.9%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 182.2% in Q1 2022, against a decline of 78.0% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $722,000 (Q1 2026), $503,000 (Q4 2025) and $784,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | 815,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 815,000.00 |
| Mar 31, 2026 | 722,000.00 |
| Dec 31, 2025 | 503,000.00 |
| Sep 30, 2025 | 784,000.00 |
| Jun 30, 2025 | 796,000.00 |
| Mar 31, 2025 | 563,000.00 |
| Dec 31, 2024 | 774,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 417,000.00 |
| Dec 31, 2023 | 519,000.00 |
| Sep 30, 2023 | 926,000.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 1.79 Mn |
API Access
Atossa Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();